EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality
Launched by FUTURE GENETICS LIMITED · Jun 12, 2019
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The EMPOWER-1 study is a research project aimed at understanding how well common medications work for patients in the UK, especially those from different ethnic backgrounds. Many clinical trials do not include enough people from minority groups, which can lead to medicines being less effective or safe for these populations when they are used in real life. By looking at various serious health conditions like heart disease, diabetes, and mental health disorders, this study hopes to find out if these medications are truly helpful and safe for all patients, thereby reducing health inequalities.
To participate in this study, you must be a patient diagnosed with one of the illnesses being studied, or if not, be a patient at an NHS site involved in the research. Participants will need to provide samples (like saliva or blood, if possible), allow access to their medical records, and fill out some questionnaires about their health and quality of life. This study is currently recruiting participants of all genders and ages, so if you or a family member might be interested, it could be a valuable opportunity to contribute to important research that aims to improve healthcare for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients or their relative/family member is diagnosed with the illness being investigated by this study.
- • 2. All NHS patients that are associated with a participating study site, but do not fall under the first bullet point above, may participate with a view that they may potentially contribute to a case control population in the research study.
- 3. Subjects agree to:
- • 1. Gift biological samples, i.e. saliva. Where practical, blood or other biological samples may be voluntarily provided by the patient.
- • 2. Provide Consent for access to medical records.
- • 3. Complete disease specific, quality of life, and study associated questionnaires.
- Exclusion Criteria:
- • 1. Patient does not provide a valid consent for study participation.
- • 2. Patient is not registered with the NHS for care.
- • 3. Patient lacking capacity, who does not have an illness that is being specifically investigated by this clinical research study.
- • 4. Person lacks capacity and where the personal consultee has not advised that the Person may enrol, in accordance with the Mental Health Act 2005.
About Future Genetics Limited
Future Genetics Limited is a pioneering clinical trial sponsor dedicated to advancing the field of genetic research and personalized medicine. With a focus on innovative therapies and cutting-edge technologies, the company conducts rigorous clinical trials aimed at exploring the nuances of genetic variations and their implications for human health. Committed to ethical standards and regulatory compliance, Future Genetics Limited collaborates with leading research institutions and healthcare professionals to ensure the highest quality of research and patient care. Through its initiatives, the company seeks to transform the landscape of medical treatment, ultimately improving outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, West Midlands, United Kingdom
Wolverhampton, West Midlands, United Kingdom
Patients applied
Trial Officials
Dr Mohammed Kamran
Study Director
Future Genetics Limited
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials